Fenistil gel for external use 0.1% tube 50 g
Dosage:
0.1% x 30g
0.1% x 50g
Category
Allergy
Scope of the medicinal product
Dermatology
Release form
Gel
Manufacturer country
Switzerland
Package quantity, pcs
one
Release form, composition and packaging
Gel for external use is homogeneous, colorless, transparent or slightly opalescent.
100 g
dimethindene maleate 100 mg
disodium edetate - 50 mg, carbomer - about 900 mg, sodium hydroxide (30% solution) - about 1 g, benzalkonium chloride - 5 mg, propylene glycol - 15 g, purified water - about 82.9 g.
30 g - aluminum tubes (1) - cardboard packs.
50 g - aluminum tubes (1) - cardboard packs.
pharmachologic effect
Blocker of histamine H1 receptors.
It has antiallergic and antipruritic effect.
Reduces increased capillary permeability associated with allergic reactions.
When applied to the skin, it reduces itching and irritation caused by allergic skin reactions.
The drug also has a pronounced local anesthetic effect.
Blocks the action of kinins, has a weak anticholinergic effect.
When applied externally, thanks to the gel base, the effect with a slight cooling effect begins after a few minutes and reaches a maximum after 1-4 hours.
Pharmacokinetics
When applied externally, it penetrates well into the skin.
The systemic bioavailability of the active substance is 10%.
Indications for use
Itching of various origins (except associated with cholestasis) with:
- itchy dermatoses
- eczema
- urticaria
- insect bites.
Sunburns, household and industrial burns (mild).
Contraindications for use
- angle-closure glaucoma
- prostatic hyperplasia
- children's age up to 1 month (especially premature ones)
- hypersensitivity to dimethindene and other components that make up the drug.
Fenistil should be prescribed with caution in the first trimester of pregnancy and during lactation (breastfeeding).
Dosage regimen
Apply externally.
The drug should be applied to the affected skin 2-4 times / day.
In cases of severe itching or widespread skin lesions, the simultaneous use of oral forms is recommended.
Overdose
Symptoms: if a large amount of the drug is accidentally swallowed, symptoms characteristic of histamine H1 receptor blockers may occur - CNS depression and drowsiness (mainly in adults), CNS stimulation and m-anticholinergic effects (especially in children), incl.
agitation, ataxia, tachycardia, hallucinations, tonic or clonic seizures, mydriasis, dry mouth, flushing of the face, urinary retention, fever.
This may be followed by a decrease in blood pressure.
Treatment: the specific antidote is unknown.
Activated charcoal, saline laxative should be prescribed
take measures to maintain the function of the cardiovascular and respiratory systems.
For the treatment of arterial hypotension, vasoconstrictors can be used.
In case of accidental overdose, the patient should consult a doctor.
Side effect
Determination of the frequency of side effects: very common (> = 1/10), often (> = 1/100 and < 1/10), infrequently (> = 1/1000 and < 1/100), rarely (> = 1/10 000 and < 1/1000), very rare (< 1/10 000), including isolated messages and reactions with an unknown frequency (cannot be estimated from the available data).
Skin and subcutaneous tissue disorders: infrequently - dry skin, burning sensation of the skin.
Allergic reactions: very rarely (post-registration data) - allergic dermatitis, including skin rash, itching.
If any of the above side effects get worse, or any other side effects appear, the patient should inform the doctor about it.
Drug interactions
The drug interaction of the drug Fenistilne is described.
Application during pregnancy and lactation
The use of the drug Fenistil in the first trimester of pregnancy is possible only after consulting a doctor.
In the II and III trimesters of pregnancy
Name ENG
FENISTIL
Clinical and pharmacological group
Antiallergic drug for external use
ATX code
Dimetindene
Dosage
0.1% x 50g
Structure
Active ingredients: dimethindene maleate 100 mg.
Excipients: disodium edetate - 50 mg, carbomer - about 900 mg, sodium hydroxide (30% solution) - about 1 g, benzalkonium chloride - 5 mg, propylene glycol - 15 g, purified water - about 82.9 g.
Indications
Itching of various origins (except for those associated with cholestasis) with: itchy dermatoses, eczema, urticaria, insect bites.
Sunburns, household and industrial burns (mild).
Storage conditions and periods
At a temperature not higher than 25 degrees.
Expiration date: 2 years
Contraindications
Hypersensitivity to dimetindene and other components that make up the drug
angle-closure glaucoma
hyperplasia of the prostate
children up to 1 month old (especially premature ones).
With caution: Fenistil® should be prescribed in the first trimester of pregnancy and during lactation (breastfeeding).
INN / Active ingredient
Dimetindene
Specifications
Category
Allergy
Scope of the medicinal product
Dermatology
Release form
Gel
Manufacturer country
Switzerland
Package quantity, pcs
one
Minimum age from
1 month
Way of introduction
On the skin
Vacation conditions
Without recipe
Brand name
Fenistil
The amount of the dosage form in the primary package
50 g
Primary packaging type
Tuba
Type of consumer packaging
Pack of cardboard
Anatomical and therapeutic characteristics
D04AA13 Dimetindene
Dosage form
Gel for external use
Item weight, g
fifty
The target audience
Children
Expiration date in days
730
Dosage (volume) of the substance in the preparation
dimethindene maleate 100 mg
Package weight, g
65
Mode of application
:
Apply externally.
The gel should be applied to the affected skin 2-4 times / day.
In cases of severe itching or widespread skin lesions, the simultaneous use of oral forms is recommended.
Pharmaco-therapeutic group
:
Antiallergic agent - H1-histamine receptor blocker
Information on technical characteristics, delivery set, country of manufacture